Company Overview of NapaJen Corporation
NapaJen Corporation develops drug delivery systems. The company involves in the development of drug delivery systems by utilizing natural transport pathways, which cells use to move molecular cargo into themselves and across internal compartments. It involves in out-licensing and offering DDS services to DNA-RNA-oligo drug development. The company was founded in 2004 and is based in Burlingame, California. It has subsidiary operations in Sapproro, Kita-Kyushu, and Tokyo, Japan.
533 Airport Boulevard
Burlingame, CA 94010
Founded in 2004
Key Executives for NapaJen Corporation
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
December 7, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact NapaJen Corporation, please visit www.napajen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.